Unicycive Therapeutics, Inc.

Unicycive Therapeutics is a medical company in California that focuses on treating diseases with significant unmet medical needs. Founded 2016 in Los Altos, California, United States by Shalabh Gupta, Unicycive Therapeutics has raised a total of $6M in funding over one round. This was a Series A round raised on March 12, 2019. The company's products are disease-modifying therapies that focus on changing the intracellular and extracellular concentrations of various electrolytes and ions by addressing the underlying mitochondrial pathology and inflammation, enabling medical practitioners to detect hyperphosphatemia, acute kidney disease and Gitelman syndrome.